ARCHIVES

NCI To Study Whether It Gets The Most From Advisors.

This article is from The Cancer Letter archive.

Vol. 28 No. 10 | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Waxman Subcommittee Hears Support For Cancer Act Renewal

March 7, 1980

FDA Clears Avastin-Interferon Combination In Renal Cancer; Interferon Role Undefined.

August 7, 2009

Senate Appropriators Plan Hearing On NCI Ouster Of Fisher

June 3, 1994

What Would You Tell a 45-Year-Old? Waxman Asks Broder

February 4, 1994

News Analysis: Generic Drug Industry’s Efforts to Eliminate Shortages Raises Antitrust Law Questions

April 27, 2012

Clinical Trials Approved By NCI In November

December 28, 2001